Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy
In view of the severe downsides of conventional cancer therapies, the quest of developing alternative strategies still remains of critical importance. In this regard, antigen cross-presentation, usually employed by dendritic cells (DCs), has been recognized as a potential solution to overcome the pr...
Main Authors: | Amina I. Makandar, Mannat Jain, Eiji Yuba, Gautam Sethi, Rajesh Kumar Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/12/2049 |
Similar Items
-
Oligosaccharide Presentation Modulates the Molecular Recognition of Glycolipids by Galectins on Membrane Surfaces
by: Marta G. Lete, et al.
Published: (2022-01-01) -
Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8+ and CD4+ T Cells
by: Wenjie Yin, et al.
Published: (2016-03-01) -
The Blessed Union of Glycobiology and Immunology: A Marriage That Worked
by: Jhenifer Santos dos Reis, et al.
Published: (2023-01-01) -
Isolation of a ß-galactoside-binding lectin from cat liver
by: L. Franco-Fraguas, et al.
Published: (2003-04-01) -
A brief history of galectin evolution
by: Juliane Günther, et al.
Published: (2023-06-01)